• α2-AR Agonist Hydrogel Reduces Osteosarcoma Recurrence via I

  2026-06-08

  This study demonstrates that α2-adrenergic receptor agonists, delivered through a thermo-sensitive hydrogel, can significantly reduce post-surgical osteosarcoma recurrence by enhancing immune-mediated tumor rejection. The findings establish a mechanistic link between α2-AR activation, T cell signaling, and improved clinical outcomes in osteosarcoma models.

• (S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl) Urea: Redox & sE

  2026-06-08

  (S)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-3-(1-(2-methylbutanoyl)piperidin-4-yl)urea (BPN-19186) is a fluorinated phenyl urea compound pivotal for redox pathway and sEH inhibition studies. Evidence supports its role in dissecting Nrf2 signaling and osteoclastogenesis, with robust solubility and validated purity ensuring reproducibility in advanced signaling pathway modulation research.

• BML-277: Potent Chk2 Inhibitor for DNA Damage Response Resea

  2026-06-07

  BML-277 is a potent and highly selective Chk2 inhibitor, offering nanomolar IC50 and Ki values. It enables precise modulation of the DNA damage checkpoint pathway and radioprotection of T-cells. This article details its mechanism, applications, and protocol best practices.

• ABCC10-Driven cGAMP Efflux Underlies Radiotherapy Resistance

  2026-06-06

  This study identifies ABCC10 as a novel transporter responsible for exporting 2'3'-cGAMP from cancer cells, thereby suppressing STING-mediated innate immune responses and contributing to radiotherapy resistance. These findings highlight ABCC10's potential as both a biomarker and therapeutic target for overcoming radioresistant tumors.

• Applied Protocols with Recombinant Human IL-15 in Immunology

  2026-06-05

  Recombinant Human IL-15 (E.coli, Tag Free, Lyophilized) from APExBIO empowers precise and reproducible T and NK cell activation workflows, supporting both classic immunology and emerging neuroimmune models. This article details stepwise protocols, troubleshooting strategies, and practical insights—bridging validated cell proliferation assays with translational research on immune modulation.

• Inflammatory Macrophage Niches Drive Kupffer Cell Plasticity

  2026-06-05

  This study uncovers how inflammatory changes in the hepatic microenvironment drive the phenotypic and functional reprogramming of Kupffer cells (KCs) during liver metastasis. By integrating advanced lineage-tracing and proliferation-recording models, the research delineates the dual mechanisms—monocyte-derived macrophage recruitment and KC plasticity—that replenish immunosuppressive macrophage populations, with implications for immunotherapy strategies.

• Nuclear cGAS-TRIM41 Axis Restricts L1 Retrotransposition via

  2026-06-04

  This study reveals a novel mechanism by which nuclear cGAS, upon CHK2-mediated phosphorylation, promotes TRIM41-dependent degradation of L1 ORF2p, restricting retrotransposition and preserving genome integrity. The findings clarify the posttranslational regulation of L1 elements—crucial for understanding DNA damage response and potential cancer interventions.

• Cucurbitacin I (JSI-124): Advanced Protocols for STAT3 Inhib

  2026-06-04

  Cucurbitacin I (JSI-124) is a gold-standard STAT3 inhibitor enabling precise dissection of cancer cell signaling and functional assays. Here, we translate cutting-edge experimental workflows and troubleshooting strategies into actionable guidance for researchers exploring tumor biology and therapy sensitization.

• Sulfo-NHS-Biotin: Precision Cell Surface Protein Labeling Wo

  2026-06-03

  Sulfo-NHS-Biotin stands out as a water-soluble, amine-reactive biotinylation reagent, enabling highly selective cell surface protein labeling without organic solvents. Its unrivaled workflow efficiency and reproducibility make it indispensable for affinity purification, immunoprecipitation, and quantitative proteomics in both standard and advanced research settings.

• Methylprednisolone: Mechanisms and Innovations in Anti-Infla

  2026-06-03

  Explore how methylprednisolone, a synthetic glucocorticoid receptor agonist, modulates inflammation at the molecular level. This article uniquely dissects its mechanistic action, practical assay implications, and translational insights from recent in vivo studies.

• Thymoquinone Counters Doxorubicin-Induced Cardiotoxicity via

  2026-06-02

  This study demonstrates that thymoquinone, a bioactive quinone from Nigella sativa, protects against doxorubicin-induced cardiotoxicity in mice by activating the Nrf2/HO-1 signaling pathway, thereby reducing ferroptosis and oxidative stress. These findings offer new mechanistic insight and practical value for researchers investigating cardioprotective strategies against chemotherapeutic injury.

• Macrophage Plasticity in Liver Metastasis: Dissecting Kupffe

  2026-06-02

  This study reveals how the inflammatory macrophage niche in liver metastasis drives the phenotypic and functional plasticity of Kupffer cells, challenging existing models of myeloid cell origin in metastatic tumors. The findings have substantial implications for targeting immunosuppressive macrophages in cancer therapy and pave the way for more nuanced approaches to tumor microenvironment modulation.

• Direct Mouse Genotyping Kit Plus: Streamlining PCR for Mouse

  2026-06-01

  The Direct Mouse Genotyping Kit Plus enables rapid genomic DNA extraction and direct PCR amplification from mouse tissues, eliminating purification steps and reducing assay time. This kit combines an optimized lysis buffer with a high-fidelity PCR master mix containing dye reagents, ensuring robust performance in mouse genotyping, transgene detection, and gene knockout validation.

• BML-277: Advanced Workflows for Chk2 Inhibitor–Driven DNA Da

  2026-06-01

  BML-277, a potent and selective Chk2 inhibitor, enables precise modulation of DNA damage response pathways and the radioprotection of T-cells. This article details experimental workflows, troubleshooting strategies, and the translational impact of BML-277, leveraging breakthrough insights from nuclear cGAS-TRIM41 axis research.

• Griseofulvin: Molecular Mechanisms and Predictive Modeling i

  2026-05-31

  Explore how Griseofulvin, a microtubule associated inhibitor, enables advanced mechanistic studies and predictive modeling in aneugenicity research. This article uniquely connects molecular disruption pathways to modern assay design, surpassing standard antifungal applications.

15127 records 1/1009 page Next 12345 下5页 Last page